The venture, announced byIntermountain in January, said it plans to have its first productsready by as early as next year. (Photo: Getty)

A drugmaking venture backed by major U.S.hospitals has picked a chief executive officer, hastening thearrival of another threat to generic pharmaceutical manufacturers.

Martin VanTrieste, 58 and a former top executive atbiotechnology giant Amgen Inc., will run the organization, anot-for-profit called Civica Rx. Dan Liljenquist, 44 and anIntermountain Healthcare executive, will be chairman. Healthsystems with a total of about 500 hospitals — includingIntermountain, HCA Healthcare Inc., Mayo Clinic and Catholic HealthInitiatives — will help govern the venture, alongside severalphilanthropies.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Health Care Reform
Cost-Containment